Brief: Natco Pharma Launches Bosentan Tablets In U.S. With 180-Day Exclusivity
20/08/2025 07:07
Aug 20 (Reuters) - Natco Pharma Ltd NATP.NS: NATCO PHARMA LTD - LAUNCHES BOSENTAN TABLETS IN U.S. WITH 180-DAY EXCLUSIVITY NATCO PHARMA LTD - MARKETING PARTNER FOR BOSENTAN IS LUPIN LIMITED Source text: ID:nBSE61JJWt Further company coverage: NATP.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees